Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


Articles published in J Mol Cell Cardiol

Retrieve available abstracts of 57 articles:
HTML format



Single Articles


    June 2021
  1. PATEREK A, Okninska M, Chajduk E, Polkowska-Motrenko H, et al
    Systemic iron deficiency does not affect the cardiac iron content and progression of heart failure.
    J Mol Cell Cardiol. 2021;159:16-27.
    PubMed     Abstract available


    May 2021
  2. YAN J, Killingsworth C, Walcott G, Zhu Y, et al
    Molecular remodeling of Cx43, but not structural remodeling, promotes arrhythmias in an arrhythmogenic canine model of nonischemic heart failure.
    J Mol Cell Cardiol. 2021 May 25. pii: S0022-2828(21)00106.
    PubMed     Abstract available


    February 2021
  3. RATTKA M, Westphal S, Gahr BM, Just S, et al
    Spen deficiency interferes with Connexin 43 expression and leads to heart failure in zebrafish.
    J Mol Cell Cardiol. 2021 Feb 4. pii: S0022-2828(21)00022.
    PubMed     Abstract available


    December 2020
  4. MORA MT, Gong JQX, Sobie EA, Trenor B, et al
    The role of beta-adrenergic system remodeling in human heart failure: A mechanistic investigation.
    J Mol Cell Cardiol. 2020 Dec 13. pii: S0022-2828(20)30344.
    PubMed     Abstract available


  5. MAMIC P, Chaikijurajai T, Tang WHW
    Gut microbiome - A potential mediator of pathogenesis in heart failure and its comorbidities: State-of-the-art review.
    J Mol Cell Cardiol. 2020 Dec 8. pii: S0022-2828(20)30340.
    PubMed     Abstract available


  6. CORTASSA S, Juhaszova M, Aon MA, Zorov DB, et al
    Mitochondrial Ca(2+), redox environment and ROS emission in heart failure: Two sides of the same coin?
    J Mol Cell Cardiol. 2020 Dec 7. pii: S0022-2828(20)30336.
    PubMed     Abstract available


  7. O'ROURKE B, Ashok D, Liu T
    Mitochondrial Ca(2+) in heart failure: Not enough or too much?
    J Mol Cell Cardiol. 2020 Dec 5. pii: S0022-2828(20)30337.
    PubMed     Abstract available


  8. NOMURA S, Komuro I
    Precision medicine for heart failure based on molecular mechanisms The Research Achievement Award Lecture.
    J Mol Cell Cardiol. 2020 Dec 1. pii: S0022-2828(20)30333.
    PubMed     Abstract available


    November 2020
  9. ROLLE IG, Crivellari I, Zanello A, Mazzega E, et al
    Heart failure impairs the mechanotransduction propeties of human cardiac pericytes.
    J Mol Cell Cardiol. 2020;151:15-30.
    PubMed     Abstract available


    September 2020
  10. ZHANG M, Yang X, Zimmerman RJ, Wang Q, et al
    CaMKII exacerbates heart failure progression by activating class I HDACs.
    J Mol Cell Cardiol. 2020 Sep 21. pii: S0022-2828(20)30287.
    PubMed     Abstract available


  11. MISTRY P, Reitz CJ, Khatua TN, Rasouli M, et al
    Circadian influence on the microbiome improves heart failure outcomes.
    J Mol Cell Cardiol. 2020 Sep 19. pii: S0022-2828(20)30286.
    PubMed     Abstract available


  12. STOLEN TO, Hoydal MA, Ahmed MS, Jorgensen K, et al
    Exercise training reveals micro-RNAs associated with improved cardiac function and electrophysiology in rats with heart failure after myocardial infarction.
    J Mol Cell Cardiol. 2020 Sep 9. pii: S0022-2828(20)30272.
    PubMed     Abstract available


    July 2020
  13. SHANG L, Yue W, Wang D, Weng X, et al
    Systolic overload-induced pulmonary inflammation, fibrosis, oxidative stress and heart failure progression through interleukin-1beta.
    J Mol Cell Cardiol. 2020 Jul 23. pii: S0022-2828(20)30230.
    PubMed     Abstract available


    May 2020
  14. TIAN C, Hu G, Gao L, Hackfort BT, et al
    Extracellular vesicular MicroRNA-27a* contributes to cardiac hypertrophy in chronic heart failure.
    J Mol Cell Cardiol. 2020 May 1. pii: S0022-2828(20)30122.
    PubMed     Abstract available


    March 2020
  15. RAZAVI AC, Bazzano LA, He J, Li S, et al
    Pseudouridine and N-formylmethionine associate with left ventricular mass index: Metabolome-wide association analysis of cardiac remodeling.
    J Mol Cell Cardiol. 2020;140:22-29.
    PubMed     Abstract available


    February 2020
  16. KELLEY RC, McDonagh B, Brumback B, Walter GA, et al
    Diaphragm weakness and proteomics (global and redox) modifications in heart failure with reduced ejection fraction in rats.
    J Mol Cell Cardiol. 2020 Feb 5. pii: S0022-2828(20)30026.
    PubMed     Abstract available


    January 2020
  17. ALI HR, Michel CR, Lin YH, McKinsey TA, et al
    Defining decreased protein succinylation of failing human cardiac myofibrils in ischemic cardiomyopathy.
    J Mol Cell Cardiol. 2020;138:304-317.
    PubMed     Abstract available


    December 2019
  18. HELISTE J, Chheda H, Paatero I, Salminen TA, et al
    Genetic and functional implications of an exonic TRIM55 variant in heart failure.
    J Mol Cell Cardiol. 2019 Dec 19. pii: S0022-2828(19)30398.
    PubMed     Abstract available


    September 2019
  19. REDDY SS, Agarwal H, Barthwal MK
    Corrigendum to "Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice" [J. Mol. Cell. Cardiol. 123 (2018) 46-57].
    J Mol Cell Cardiol. 2019 Sep 12. pii: S0022-2828(19)30173.
    PubMed    


    July 2019
  20. TURER A, Altamirano F, Schiattarella GG, May H, et al
    Remodeling of substrate consumption in the murine sTAC model of heart failure.
    J Mol Cell Cardiol. 2019 Jul 21. pii: S0022-2828(18)30988.
    PubMed     Abstract available


    April 2019
  21. ALEXANIAN M, Padmanabhan A, McKinsey TA, Haldar SM, et al
    Epigenetic therapies in heart failure.
    J Mol Cell Cardiol. 2019 Apr 13. pii: S0022-2828(19)30063.
    PubMed     Abstract available


    March 2019
  22. AHMAD F, Singh AP, Tomar D, Rahmani M, et al
    Cardiomyocyte-GSK-3alpha promotes mPTP opening and heart failure in mice with chronic pressure overload.
    J Mol Cell Cardiol. 2019;130:65-75.
    PubMed     Abstract available


    February 2019
  23. OH JG, Jang SP, Yoo J, Lee MA, et al
    Role of the PRC2-Six1-miR-25 signaling axis in heart failure.
    J Mol Cell Cardiol. 2019 Feb 13. pii: S0022-2828(18)30916.
    PubMed     Abstract available


    December 2018
  24. BOITARD SE, Marc Y, Keck M, Mougenot N, et al
    Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice.
    J Mol Cell Cardiol. 2018 Dec 29. pii: S0022-2828(18)30783.
    PubMed     Abstract available


    November 2018
  25. WOULFE KC, Bruns DR
    From pediatrics to geriatrics: Mechanisms of heart failure across the life-course.
    J Mol Cell Cardiol. 2018 Nov 17. pii: S0022-2828(18)30960.
    PubMed     Abstract available


  26. BOECKEL JN, Perret MF, Glaser SF, Seeger T, et al
    Identification and regulation of the long non-coding RNA Heat2 in heart failure.
    J Mol Cell Cardiol. 2018;126:13-22.
    PubMed     Abstract available


    October 2018
  27. MATSUMURA N, Takahara S, Maayah ZH, Parajuli N, et al
    Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites.
    J Mol Cell Cardiol. 2018 Oct 28. pii: S0022-2828(18)30720.
    PubMed     Abstract available


    August 2018
  28. REDDY SS, Agarwal H, Barthwal MK
    Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice.
    J Mol Cell Cardiol. 2018 Aug 20. pii: S0022-2828(18)30815.
    PubMed     Abstract available


  29. PAPPAS CT, Farman GP, Mayfield RM, Konhilas JP, et al
    Cardiac-specific knockout of Lmod2 results in a severe reduction in myofilament force production and rapid cardiac failure.
    J Mol Cell Cardiol. 2018 Aug 10. pii: S0022-2828(18)30789.
    PubMed     Abstract available


  30. HUANG CY, Lai CH, Kuo CH, Chiang SF, et al
    Inhibition of ERK-Drp1 signaling and mitochondria fragmentation alleviates IGF-IIR-induced mitochondria dysfunction during heart failure.
    J Mol Cell Cardiol. 2018;122:58-68.
    PubMed     Abstract available


  31. CHANG SL, Hsiao YW, Tsai YN, Lin SF, et al
    Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure.
    J Mol Cell Cardiol. 2018 Aug 7. pii: S0022-2828(18)30767.
    PubMed     Abstract available


    July 2018
  32. ERNENS I, Lumley AI, Devaux Y
    Restoration of cardiac function after anaemia-induced heart failure in zebrafish.
    J Mol Cell Cardiol. 2018 Jul 13. pii: S0022-2828(18)30537.
    PubMed     Abstract available


    May 2018
  33. ZHANG J, Levy D, Oydanich M, Bravo C, et al
    A novel adenylyl cyclase type 5 inhibitor that reduces myocardial infarct size even when administered after coronary artery reperfusion.
    J Mol Cell Cardiol. 2018 May 22. pii: S0022-2828(18)30175.
    PubMed     Abstract available


    April 2018
  34. WANG S, Wu J, You J, Shi H, et al
    HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
    J Mol Cell Cardiol. 2018 Apr 4. pii: S0022-2828(18)30089.
    PubMed     Abstract available


    March 2018
  35. KAIN V, Ingle KA, Kabarowski J, Barnes S, et al
    Genetic deletion of 12/15 lipoxygenase promotes effective resolution of inflammation following myocardial infarction.
    J Mol Cell Cardiol. 2018 Mar 8. pii: S0022-2828(18)30067.
    PubMed     Abstract available


    November 2017
  36. PLUTEANU F, Nikonova Y, Holzapfel A, Herzog B, et al
    Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failure.
    J Mol Cell Cardiol. 2017 Nov 27. pii: S0022-2828(17)30355.
    PubMed     Abstract available


    October 2017
  37. GRANDI E, Dobrev D
    Non-ion channel therapeutics for heart failure and atrial fibrillation: Are CaMKII inhibitors ready for clinical use?
    J Mol Cell Cardiol. 2017 Oct 25. pii: S0022-2828(17)30334.
    PubMed     Abstract available


    September 2017
  38. ZHANG R, Shen Y, Zhou L, Sangwung P, et al
    Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure.
    J Mol Cell Cardiol. 2017 Sep 4. pii: S0022-2828(17)30303.
    PubMed     Abstract available


    July 2017
  39. POLZIN A, Piayda K, Keul P, Dannenberg L, et al
    Plasma sphingosine-1-phosphate concentrations are associated with systolic heart failure in patients with ischemic heart disease.
    J Mol Cell Cardiol. 2017 Jul 11. pii: S0022-2828(17)30149.
    PubMed     Abstract available


    April 2017
  40. WILLIS MS, Holley DW, Wang Z, Chen X, et al
    BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility.
    J Mol Cell Cardiol. 2017;105:99-109.
    PubMed     Abstract available


    March 2017
  41. WALWEEL K, Molenaar P, Imtiaz MS, Denniss A, et al
    Ryanodine receptor modification and regulation by intracellular Ca2+ and Mg2+ in healthy and failing human hearts.
    J Mol Cell Cardiol. 2017;104:53-62.
    PubMed     Abstract available


    January 2017
  42. ALVARADO FJ, Chen X, Valdivia HH
    Ablation of the cardiac ryanodine receptor phospho-site Ser2808 does not alter the adrenergic response or the progression to heart failure in mice. Elimination of the genetic background as critical variable.
    J Mol Cell Cardiol. 2017 Jan 5. pii: S0022-2828(17)30001.
    PubMed     Abstract available


  43. PIQUEREAU J, Moulin M, Zurlo G, Mateo P, et al
    Cobalamin and folate protect mitochondrial and contractile functions in a murine model of cardiac pressure overload.
    J Mol Cell Cardiol. 2017;102:34-44.
    PubMed     Abstract available


    December 2016
  44. O'CONNELL TD, Block RC, Huang SP, Shearer GC, et al
    omega3-Polyunsaturated Fatty Acids for Heart Failure: Effects of Dose on Efficacy and Novel Signaling through Free Fatty Acid Receptor 4.
    J Mol Cell Cardiol. 2016 Dec 13. pii: S0022-2828(16)30445.
    PubMed     Abstract available


    March 2016
  45. CAO L, Qin X, Peterson MR, Haller SE, et al
    CARD9 knockout ameliorates myocardial dysfunction associated with high fat diet-induced obesity.
    J Mol Cell Cardiol. 2016;92:185-95.
    PubMed     Abstract available


  46. STRATTON MS, McKinsey TA
    Epigenetic regulation of cardiac fibrosis.
    J Mol Cell Cardiol. 2016;92:206-13.
    PubMed     Abstract available


  47. JAMEEL MN, Xiong Q, Mansoor A, Bache RJ, et al
    ATP sensitive K(+) channels are critical for maintaining myocardial perfusion and high energy phosphates in the failing heart.
    J Mol Cell Cardiol. 2016;92:116-21.
    PubMed     Abstract available


  48. TRAYNHAM CJ, Hullmann J, Koch WJ
    "Canonical and non-canonical actions of GRK5 in the heart".
    J Mol Cell Cardiol. 2016;92:196-202.
    PubMed     Abstract available


  49. FU L, Wei CC, Powell PC, Bradley WE, et al
    Increased fibroblast chymase production mediates procollagen autophagic digestion in volume overload.
    J Mol Cell Cardiol. 2016;92:1-9.
    PubMed     Abstract available


  50. FELDMAN AM, Gordon J, Wang J, Song J, et al
    BAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytes.
    J Mol Cell Cardiol. 2016;92:10-20.
    PubMed     Abstract available


    February 2016
  51. PINEDA-SANABRIA SE, Robertson IM, Sun YB, Irving M, et al
    Probing the mechanism of cardiovascular drugs using a covalent levosimendan analog.
    J Mol Cell Cardiol. 2016 Feb 4. pii: S0022-2828(16)30031.
    PubMed     Abstract available


  52. VALIENTE-ALANDI I, Schafer AE, Blaxall BC
    Extracellular matrix-mediated cellular communication in the heart.
    J Mol Cell Cardiol. 2016;91:228-37.
    PubMed     Abstract available


  53. SAMANTA A, Dawn B
    IL-10 for cardiac autophagy modulation: New direction in the pursuit of perfection.
    J Mol Cell Cardiol. 2016;91:204-6.
    PubMed    


  54. MOORE-MORRIS T, Cattaneo P, Puceat M, Evans SM, et al
    Origins of cardiac fibroblasts.
    J Mol Cell Cardiol. 2016;91:1-5.
    PubMed     Abstract available


  55. YANO T, Shimoshige S, Miki T, Tanno M, et al
    Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy.
    J Mol Cell Cardiol. 2016;91:6-9.
    PubMed     Abstract available


    December 2015
  56. KUBOTA A, Takano H, Wang H, Hasegawa H, et al
    DPP-4 inhibition has beneficial effects on the heart after myocardial infarction.
    J Mol Cell Cardiol. 2015 Dec 28. pii: S0022-2828(15)30165.
    PubMed     Abstract available


  57. LINDSEY ML, Iyer RP, Jung M, DeLeon-Pennell KY, et al
    Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.
    J Mol Cell Cardiol. 2015 Dec 22. pii: S0022-2828(15)30155.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: